DRW Securities LLC grew its stake in MetLife, Inc. (NYSE:MET - Free Report) by 378.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,836 shares of the financial services provider's stock after purchasing an additional 42,573 shares during the quarter. DRW Securities LLC's holdings in MetLife were worth $4,440,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. PFG Investments LLC increased its position in MetLife by 8.9% during the third quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider's stock worth $525,000 after acquiring an additional 520 shares during the period. M&G Plc bought a new position in MetLife in the 2nd quarter valued at about $2,346,000. B. Metzler seel. Sohn & Co. Holding AG bought a new position in MetLife in the 3rd quarter valued at about $2,960,000. PGGM Investments increased its holdings in MetLife by 1,803.4% in the 2nd quarter. PGGM Investments now owns 69,796 shares of the financial services provider's stock valued at $4,899,000 after buying an additional 66,129 shares during the period. Finally, Granite Bay Wealth Management LLC bought a new position in MetLife in the 2nd quarter valued at about $585,000. 89.81% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on MET. Piper Sandler raised their price target on shares of MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a research note on Wednesday, October 2nd. Jefferies Financial Group raised their price target on shares of MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a research note on Friday, September 27th. Morgan Stanley reduced their price target on shares of MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a research note on Monday, August 19th. Bank of America reduced their price target on shares of MetLife from $99.00 to $96.00 and set a "buy" rating on the stock in a research note on Thursday, August 1st. Finally, Wells Fargo & Company lifted their target price on shares of MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 5th. Fourteen analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $88.46.
Read Our Latest Stock Analysis on MET
MetLife Trading Up 0.9 %
Shares of NYSE:MET traded up $0.78 during mid-day trading on Monday, hitting $87.37. The company had a trading volume of 1,395,695 shares, compared to its average volume of 3,309,429. The firm has a fifty day moving average price of $82.48 and a 200 day moving average price of $76.08. The company has a market capitalization of $60.50 billion, a PE ratio of 17.46, a price-to-earnings-growth ratio of 0.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $62.81 and a one year high of $87.63.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.50%. MetLife's dividend payout ratio is currently 43.95%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.